Abstract:Objective To study the expression of ABCG2, SFRP2, BRMS1 and HPA and detect their clinicopathological significances in the benign and malignatnt lesions of the gallbladder.Methods EnVisiom immunohistochemical method for determining the expressions of ABCG2, SFRP2,BRMS1 and HPA was used in paraffin-embedded sections of surgical resected specimens from gallbladder adenocarcinoma (n =108), peritumoral tissues (n =46 ), adenomatous polyp (n =15 ), and chronic cholecystitis ( n =35 ).Results The positive rates of ABCG2 and HPA expression were significantly higher in gallbladder adenocarcinoma than that in peritumoral tissues, adenomatous polyp and chronic cholecystitis (P ＜ 0. 05 or P ＜ 0. 01 ) ; The positive rates of SFRP2 and BRMS1 expression were significantly lower in gallbladder adenocarcinoma than that in peritumoral tissues, adenomatous polyp and chronic cholecystitis(P ＜0. 05 or P ＜0. 01 ). The positive cases of ABCG2 and/or HPA as well as negative ones of SFRP2 and/or BRMS1 in the benign lesions showed moderately-or severely-atypical hyperplasia of gallbladder epithelium. The frequency of samples with positive staining for ABCG2 and/or HPA in cases with small tumor volume (diameter ＜ 2 cm), no lymph node metastasis, and no invasion into surrounding tissues was significantly lower than that in cases with larger tumor volume (diameter ＞ 2 cm ), lymph node metastasis, and invasion into surrounding tissues ( P ＜ 0.05 or P ＜ 0. 01 ). However, compared with ABCG2 and/or HPA, the expression of SFRP2 and/or BRMS1 showed an opposite correlation in these cases ( P ＜ 0. 05 or P ＜0. 01 ). Unitivariate Kaplan-Meier analysis showed that increased expressions of ABCG2 (P =0. 019) and HPA ( P =0. 016) or decreased expression of SFRP2 ( P =0. 019) and BRMS1 ( P =0. 008 )were associated with poorer overall survival, respectively. Multivariate Cox regression analysis showed that increased expression of ABCG2 (P =0. 018 ) and HPA ( P =0. 019) and/or decreased expression of SFRP2 (P =0. 015 ) and BRMS1 ( P =0. 011 ) were independently poor-prognostic predictors in gallbladder adenocarcinoma. Conclusions The expression of ABCG2, SFRP2, BRMS1 or HPA might be closely related to the carcinogenesis, clinical biological behaviors, and prognosis of gallbladder adenocarcinoma.

Expression of Nrf2 and HO-1 and Its Correlation with Clinicopathological Features of Primary Gallbladder Carcinoma

The expression and significance of Nrf2 in primary gallbladder

The Expressions of NRF2 and MRP2 in Primary Gallbladder Carcinoma

VEGF, Flt-1 and KDR Mrna and Protein Expression in Primary Gallbladder Carcinoma and Their Correlation with Primary Gallbladder Carcinoma Clinicopathological Characteristics

Expression and significance of HO-1 and MRP2 in primary gallbladder carcinoma

Correlation of Nrf2, Ho-1, and Mrp3 in Gallbladder Cancer and Their Relationships to Clinicopathologic Features and Survival

Expression and Prognostic Value of NRF2 and Ho-1 in Hepatocellular Carcinoma

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

Expression level and clinical significance of co-stimulator B7-H1 and B7-H3 in patients with gallbladder cancer

Clinical Implication of Keap1 and Phosphorylated Nrf2 Expression in Hepatocellular Carcinoma.

Expression of Oncoprotein C-Erbb-2 and Nm23h1 in Gallbladder Carcinoma and Its Significance

Expression of ABCG2, SFRP2, BRMS1 and HPA in Benign and Malignant Lesions of the Gallbladder and Their Clinicopathological Significances

Expression of Cdx2 and Hepatocyte Antigen in Benign and Malignant Lesions of Gallbladder and Its Correlation with Histopathologic Type and Clinical Outcome

Prognostic Implications of Estrogen Receptor 1 and Vascular Endothelial Growth Factor A Expression in Primary Gallbladder Carcinoma.

Expression and Clinical Significance of P27 , CyclinD1 and CyclinE in the Primary Gallbladder Carcinoma

Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder.

Significance of Expression of Epidermal Growth Factor (EGF) and Its Receptor (EGFR) in Chronic Cholecystitis and Gallbladder Carcinoma

Expressions and Clinical Significance of TGF-β1, MMP-2 in Gallbladder Carcinoma

Expression and Clinical Significance of CyclinE,P27 in Primary Gallbladder Carci Noma

Relationship Between Expression of Ezrin Protein in Primary Carcinoma of Gallbladder and Positive Rates of CEA and CA19-9 in Serum

Expression of Podoplanin in human primary gallbladder carcinomas and its clinical significance